RIFINAH

This brand name is authorized in Spain, France, Hong Kong, Ireland, Malta, Netherlands, New Zealand, United Kingdom, South Africa

Active ingredients

The drug RIFINAH contains a combination of these active pharmaceutical ingredients (APIs):

1 Rifampicin
UNII VJT6J7R4TR - RIFAMPIN

Rifampicin is an active bactericidial antituberculosis drug which is particularly active against the rapidly growing extracellular organisms and also has bactericidial activity intracellularly. Rifampicin inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme.

Read about Rifampicin
2 Isoniazid
UNII V83O1VOZ8L - ISONIAZID

Isoniazid is used mainly in the treatment of pulmonary tuberculosis but it appears to be effective also in the treatment of extrapulmonary lesions, including meningitis and genito-urinary disease.

Read about Isoniazid

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
RIFINAH Coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J04AM02 Rifampicin and isoniazid J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AM Combinations of drugs for treatment of tuberculosis
Discover more medicines within J04AM02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ES Centro de informaciรณn online de medicamentos de la AEMPS Identifier(s): 54213
Country: FR Base de donnรฉes publique des mรฉdicaments Identifier(s): 63898512
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 146592, 19240, 19242
Country: HK Department of Health Drug Office Identifier(s): 27590, 27593
Country: IE Health Products Regulatory Authority Identifier(s): 64386, 64394
Country: MT Medicines Authority Identifier(s): MA1359/02801, MA1359/02802
Country: NL Z-Index G-Standaard, PRK Identifier(s): 93890
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 2083, 2084
Country: ZA Health Products Regulatory Authority Identifier(s): A40/20.2.3/0534, A40/20.2.3/0535

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.